NO20070345L - Anvendelse av DNA molekyl som vaksine adjuvant - Google Patents

Anvendelse av DNA molekyl som vaksine adjuvant

Info

Publication number
NO20070345L
NO20070345L NO20070345A NO20070345A NO20070345L NO 20070345 L NO20070345 L NO 20070345L NO 20070345 A NO20070345 A NO 20070345A NO 20070345 A NO20070345 A NO 20070345A NO 20070345 L NO20070345 L NO 20070345L
Authority
NO
Norway
Prior art keywords
dna molecule
vaccine
fragment
variant
host cell
Prior art date
Application number
NO20070345A
Other languages
English (en)
Inventor
Audun Helge Nerland
Niels Lorenzen
Ingunn Sommerset
Original Assignee
Forinnova As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0413973A external-priority patent/GB0413973D0/en
Priority claimed from GB0414091A external-priority patent/GB0414091D0/en
Application filed by Forinnova As filed Critical Forinnova As
Publication of NO20070345L publication Critical patent/NO20070345L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/30011—Nodaviridae
    • C12N2770/30034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer anvendelse av et DNA-molekyl som koder for et antigen (og spesielt som koder for et bakterie- eller virus-glykoprotein, fortrinnsvis et rhabdovirus-glykoprotein) som uttrykkes på overflaten av en vertscelle, eller en variant, eller et fragment derav, ved fremstilling av et medikament for anvendelse som vaksineadjuvans eller for å forsterke de immunstimulerende egenskaper eller vaksinasjonsegenskapene hos et vaksinemolekyl, eller for å forsterke immunresponsen overfor et vaksinemolekyl. Et preparat omfattende nevnte DNA-molekyl som koder for et antigen som uttrykkes på overflaten av en vertscelle, eller en variant, eller et fragment derav, og et vaksinemolekyl, er også tilveiebrakt. Et ytterligere aspekt ved foreliggende oppfinnelse tilveiebringer anvendelse av DNA-molekylet som koder for et antigen som uttrykkes på overflaten av en vertscelle, eller en variant, eller et fragment derav, ved fremstilling av et preparat som kan forbedre eller øke elimineringen av andre fremmede DNA-molekyler fra en organisme.
NO20070345A 2004-06-22 2007-01-18 Anvendelse av DNA molekyl som vaksine adjuvant NO20070345L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0413973A GB0413973D0 (en) 2004-06-22 2004-06-22 Use
GB0414091A GB0414091D0 (en) 2004-06-23 2004-06-23 Use
PCT/GB2005/002472 WO2005123121A2 (en) 2004-06-22 2005-06-22 Use of dna molecule as vaccine adjuvant

Publications (1)

Publication Number Publication Date
NO20070345L true NO20070345L (no) 2007-03-02

Family

ID=34981463

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070345A NO20070345L (no) 2004-06-22 2007-01-18 Anvendelse av DNA molekyl som vaksine adjuvant

Country Status (4)

Country Link
EP (1) EP1784208A2 (no)
CA (1) CA2572171A1 (no)
NO (1) NO20070345L (no)
WO (1) WO2005123121A2 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100436599C (zh) * 2006-05-12 2008-11-26 中国水产科学研究院黄海水产研究所 半滑舌鳎雌性特异aflp片段及遗传性别鉴定的pcr方法
CN101914529B (zh) * 2010-07-29 2012-03-14 中国水产科学研究院黄海水产研究所 半滑舌鳎性别连锁的微卫星标记及遗传性别鉴定方法

Also Published As

Publication number Publication date
CA2572171A1 (en) 2005-12-29
WO2005123121A3 (en) 2006-06-15
EP1784208A2 (en) 2007-05-16
WO2005123121A2 (en) 2005-12-29

Similar Documents

Publication Publication Date Title
NO20072470L (no) Malariaigangsetter/forsterkervaksine
ATE494906T1 (de) Von zellen stammende virale impfstoffe mit geringen mengen an rest-zell-dna
DK1898948T3 (da) Polyriboinosinsyre-polyribocytidylsyre-baseret adjuvans
NO20090194L (no) Rekombinant viral vaksine
WO2008039267A3 (en) Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions
JP2010532656A5 (no)
WO2011146933A3 (en) Universal dengue virus sequences and methods of use
WO2007008918A3 (en) Virus vaccines comprising envelope-bound immunomodulatory proteins and methods of use thereof
ATE470673T1 (de) Impfstoffe mit lawsoniaintrazellularis- untereinheit
NO20075648L (no) Vaksinesammensetning
MX2019003682A (es) Antigenos de consenso del virus sincitial respiratorio humano, constructos de acido nucleico y vacunas hechas de estos, y metodos para utilizarlas.
JP2014507146A5 (no)
WO2008103819A3 (en) Chimeric newcastle disease virus vlps
Gasmi et al. A global survey in the developmental landscape of possible vaccination strategies for COVID-19
WO2009074861A3 (en) Improved vaccine
WO2006076587A3 (en) Peptides for delivery of mucosal vaccines
NO20070345L (no) Anvendelse av DNA molekyl som vaksine adjuvant
TW201938578A (zh) 腸病毒疫苗
Li et al. A recombinant protein containing highly conserved hemagglutinin residues 81-122 of influenza H5N1 induces strong humoral and mucosal immune responses
ATE450545T1 (de) Impfstoff mit lawsonia intracellularis- untereinheit
WO2003095480A3 (en) Brachyspira hyodysenteriae vaccine
KR20210146392A (ko) 침습 플라스미드 항원 b의 최적화된 무세포 합성 및 관련 조성물 및 사용 방법
NO20081541L (no) Ny sjo-lus vaksine
WO2004007726A3 (en) Brachyspira hyodysenteriae vaccine
TW202317600A (zh) 預防多種病毒感染的多價疫苗

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application